Prevent Cancer Foundation Celebrates 25 Years

Carolyn "Bo" Aldige

C3 congratulates the Prevent Cancer Foundation on their 25th anniversary this month.

We are proud of the work they do, especially in encouraging screening to prevent colorectal cancer.  This March they will sponsor the 12th Dialogue for Action Prevention Hits the Headlines.

Prevent Cancer also sponsors the Super Colon Tour, an educational program accompanied by a large crawl-through colon.  2010 tour appearances are being scheduled now. Continue reading…

Posted by Kate Murphy on December 16th, 2009
Posted in: C3 News, Research & Treatment News | No Comments »
Tags: colorectal cancer prevention

124,000 New Cancers In Europe Due to Obesity

ECCO/ESMO UPDATE — BERLIN 2009

Being overweight was a key reason for at least 124,000 new cancers in European countries in 2008, including nearly 24,000 from colorectal cancer.

3.2 percent of new cancer diagnoses in men and 8.8 percent of women’s cancers could be attributed to excessive body mass index (BMI).  This was a dramatic increase from  2002 that found 70,000 cases of cancer directly related to obesity out of 2.2 million European cancers overall. Continue reading…

Posted by Kate Murphy on September 30th, 2009
Posted in: Research & Treatment News | No Comments »
Tags: colorectal cancer prevention, obesity

Aspirin Prevents Lynch Syndrome Cancers

ECCO/ESMO UPDATE — BERLIN 2009

Although initial reports found no reduction in polyps or cancer in people with Lynch syndrome who took aspirin and/or resistant starch supplements, longer follow-up tells a difference story.

About five years after trial participants began taking aspirin or a placebo, differences began to emerge. Even though patients in the trial only took aspirin for four years, later followup found significantly fewer colon colon cancers among those who had used  aspirin, as well as fewer Lynch-related cancers overall.   There were almost three times as many colon cancers in Lynch carriers who took a placebo compared to those who used aspirin. Continue reading…

Posted by Kate Murphy on September 24th, 2009
Posted in: Research & Treatment News | No Comments »
Tags: aspirin, colorectal cancer prevention, Lynch syndrome

CDC Expands Screening for Uninsured

The Centers for Disease Control has awarded $22 million to 26 states and tribal organizations to provide colorectal cancer screening to the uninsured and underinsured from age 50 to 64.

Through the Colorectal Cancer Control Program, five-year grants ranging from $358,283 to $1.1 million will support support screening and diagnostic follow–up care, data collection, outreach and public education, health care provider education, and program evaluation.  Projects can choose from among recommended screening methods including colonoscopy, sigmoidoscopy, or stool tests.

The new funding builds on the successful CDC Colorectal Cancer Screening Demonstration Program in five sites across the US, including Baltimore, Long Island, Seattle and King County, Nebraska, and Missouri. Continue reading…

Posted by Kate Murphy on September 10th, 2009
Posted in: Policy & Advocacy News, Research & Treatment News | No Comments »
Tags: CDC, colorectal cancer prevention, colorectal cancer screening, uninsured

Hormone Replacement Therapy Reduces Colorectal Cancer Risk

Women in Israel who used hormone replacement therapy (HRT) during and after menopause had about a 63 percent reduced risk of getting colon or rectal cancer.

However, those women who were active in sports or who took aspirin regularly didn’t benefit from HRT. Continue reading…

Posted by Kate Murphy on August 26th, 2009
Posted in: Research & Treatment News | No Comments »
Tags: colorectal cancer prevention, hormone replacement therapy